Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jan 15, 2025; 17(1): 99272
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99272
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99272
Group | CR | PR | SD | PD | Objective mitigation rate |
Observation (n = 58) | 5 (8.62) | 27 (46.55) | 23 (39.66) | 3 (5.17) | 32 (55.17) |
Control (n = 58) | 1 (1.72) | 20 (34.48) | 29 (50.00) | 8 (13.79) | 21 (36.21) |
χ2 | 4.204 | ||||
P value | 0.040 |
Group | CD3+ (%) | CD4+ (%) | CD8+ (%) | CD4+/CD8+ | Treg cell (%) | NK cell (%) |
Observation (n = 58) | 42.86 ± 4.86 | 26.95 ± 3.10 | 31.04 ± 2.08 | 0.87 ± 0.12 | 5.80 ± 1.04 | 30.24 ± 4.85 |
Control (n = 58) | 43.10 ± 4.96 | 27.05 ± 3.18 | 30.85 ± 2.12 | 0.88 ± 0.13 | 5.76 ± 1.08 | 29.82 ± 4.90 |
t | 0.263 | 0.171 | 0.487 | 0.430 | 0.203 | 0.464 |
P value | 0.793 | 0.864 | 0.627 | 0.668 | 0.839 | 0.644 |
Group | CD3+ (%) | CD4+ (%) | CD8+ (%) | CD4+/CD8+ | Treg cell (%) | NK cell (%) |
Observation (n = 58) | 61.28 ± 5.84a | 38.84 ± 3.58a | 21.58 ± 2.08a | 1.81 ± 0.18a | 2.08 ± 0.65a | 21.26 ± 3.28a |
Control (n = 58) | 52.84 ± 5.80a | 33.10 ± 3.48a | 24.63 ± 2.12a | 1.34 ± 0.14a | 3.07 ± 0.72a | 24.95 ± 3.35a |
t | 7.809 | 8.756 | 7.821 | 15.697 | 7.773 | 5.994 |
P value | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
Group | White blood cell reduction | Platelet reduction | Liver and kidney function injury | |||
Level 1-2 | Level 3-4 | Level 1-2 | Level 3-4 | Level 1-2 | Level 3-4 | |
Observation (n = 58) | 22 (37.93) | 0 | 18 (31.03) | 0 | 13 (22.41) | 0 |
Control (n = 58) | 31 (53.45) | 3 (5.17) | 20 (34.48) | 2 (3.45) | 23 (39.66) | 0 |
χ2 | 4.971 | 0.611 | 4.028 | |||
P value | 0.026 | 0.435 | 0.045 |
Group | Nausea and vomiting | Hand-foot syndrome | Senses the abnormalities in peripheral nerves | |||
Level 1-2 | Level 3-4 | Level 1-2 | Level 3-4 | Level 1-2 | Level 3-4 | |
Control (n = 58) | 21 (36.21) | 1 (1.72) | 3 (5.17) | 0 | 6 (10.34) | 0 |
Observation (n = 58) | 33 (56.90) | 3 (5.17) | 5 (8.62) | 0 | 9 (15.52) | 0 |
χ2 | 6.759 | 0.134 | 0.689 | |||
P value | 0.009 | 0.714 | 0.406 |
- Citation: Shi XJ, Song Y, Liang XX, Chen T, Hao HY, Han X, Chen YN. Effects of Shenqi Xiangyi granules in advanced gastric cancer chemotherapy. World J Gastrointest Oncol 2025; 17(1): 99272
- URL: https://www.wjgnet.com/1948-5204/full/v17/i1/99272.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i1.99272